Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Diamond-Blackfan anemia (DBA) is a congenital pure red cell aplasia characterized by macrocytic anemia, reticulocytopenia, and in ~40–50% of patients, congenital anomalies (MONDO:0015253). Heterozygous loss-of-function variants in RPL35A cause DBA via haploinsufficiency.
Genetic evidence supports an autosomal dominant inheritance: a multi-institutional study of 45 individuals with pathogenic RPL35A germline variants and 21 additional unrelated cases establish RPL35A as a causative DBA gene (PMID:32241839). Moreover, six patients with 3q27.2–qter deletions encompassing RPL35A presented with DBA features (PMID:28432740), confirming dosage sensitivity.
The spectrum of pathogenic alleles includes single-nucleotide frameshift and splice-site mutations as well as large gene deletions. A representative variant is c.118_119del (p.Glu40fs), identified in a Russian DBA cohort (PMID:25946618).
Functional studies in zebrafish demonstrate that morpholino-mediated knockdown of rpl35a leads to a striking reduction of erythroid cells and developmental defects in head and tail, mirroring DBA erythropoietic failure (PMID:18653748).
Genotype-phenotype correlations reveal that large RPL35A deletions are significantly associated with steroid-resistant anemia, neutropenia, craniofacial and gastrointestinal abnormalities (p<0.01) compared to patients with other variant classes (PMID:32241839).
One patient with a 3q27.2–qter deletion presented immunodeficiency in addition to DBA, but normal RNF168 function excluded RIDDLE syndrome, suggesting immunodeficiency may arise from secondary effects or unrecognized gene interactions (PMID:28432740).
Collectively, these data achieve a definitive clinical validity classification and support robust diagnostic testing for RPL35A in suspected DBA cases. Key take-home: RPL35A haploinsufficiency underlies an autosomal dominant ribosomopathy with characteristic erythroid failure and multisystem involvement, guiding genetic diagnosis and management.
Gene–Disease AssociationDefinitive66 unrelated probands including 45 from a multi-institutional cohort, 21 literature cases, and 6 deletion carriers; segregation data and concordant functional studies Genetic EvidenceStrong66 probands with loss-of-function and deletion variants in RPL35A; autosomal dominant inheritance and variant spectrum capped per ClinGen guidelines Functional EvidenceModerateZebrafish rpl35a knockdown replicates erythroid defects consistent with human DBA |